232 related articles for article (PubMed ID: 36919699)
1. HMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation.
Chia L; Wang B; Kim JH; Luo LZ; Shuai S; Herrera I; Chen SY; Li L; Xian L; Huso T; Heydarian M; Reddy K; Sung WJ; Ishiyama S; Guo G; Jaffee E; Zheng L; Cope LM; Gabrielson K; Wood L; Resar L
J Clin Invest; 2023 Mar; 133(6):. PubMed ID: 36919699
[TBL] [Abstract][Full Text] [Related]
2. HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression.
Li L; Kim JH; Lu W; Williams DM; Kim J; Cope L; Rampal RK; Koche RP; Xian L; Luo LZ; Vasiljevic M; Matson DR; Zhao ZJ; Rogers O; Stubbs MC; Reddy K; Romero AR; Psaila B; Spivak JL; Moliterno AR; Resar LMS
Blood; 2022 May; 139(18):2797-2815. PubMed ID: 35286385
[TBL] [Abstract][Full Text] [Related]
3. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
Liau SS; Rocha F; Matros E; Redston M; Whang E
Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
[TBL] [Abstract][Full Text] [Related]
4. HMGA1: a master regulator of tumor progression in triple-negative breast cancer cells.
Shah SN; Cope L; Poh W; Belton A; Roy S; Talbot CC; Sukumar S; Huso DL; Resar LM
PLoS One; 2013; 8(5):e63419. PubMed ID: 23658826
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
6. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K
Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719
[No Abstract] [Full Text] [Related]
7. HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma.
Hristov AC; Cope L; Di Cello F; Reyes MD; Singh M; Hillion JA; Belton A; Joseph B; Schuldenfrei A; Iacobuzio-Donahue CA; Maitra A; Resar LM
Mod Pathol; 2010 Jan; 23(1):98-104. PubMed ID: 19820691
[TBL] [Abstract][Full Text] [Related]
8. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
[TBL] [Abstract][Full Text] [Related]
9. FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression.
Zhao X; Xu F; Dominguez NP; Xiong Y; Xiong Z; Peng H; Shay C; Teng Y
Mol Carcinog; 2018 Nov; 57(11):1616-1625. PubMed ID: 30074276
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
11. Generation of an in vitro 3D PDAC stroma rich spheroid model.
Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
[TBL] [Abstract][Full Text] [Related]
12. High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.
Zhang Y; Ma T; Yang S; Xia M; Xu J; An H; Yang Y; Li S
Mol Cell Biochem; 2011 Nov; 357(1-2):363-71. PubMed ID: 21656127
[TBL] [Abstract][Full Text] [Related]
13. HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma.
Liau SS; Whang E
Clin Cancer Res; 2008 Mar; 14(5):1470-7. PubMed ID: 18316571
[TBL] [Abstract][Full Text] [Related]
14. The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.
Hillion J; Smail SS; Di Cello F; Belton A; Shah SN; Huso T; Schuldenfrei A; Nelson DM; Cope L; Campbell N; Karikari C; Aderinto A; Maitra A; Huso DL; Resar LM
Pancreatology; 2012; 12(4):372-9. PubMed ID: 22898640
[TBL] [Abstract][Full Text] [Related]
15. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.
Schuldenfrei A; Belton A; Kowalski J; Talbot CC; Di Cello F; Poh W; Tsai HL; Shah SN; Huso TH; Huso DL; Resar LM
BMC Genomics; 2011 Nov; 12():549. PubMed ID: 22053823
[TBL] [Abstract][Full Text] [Related]
16. HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma.
Piscuoglio S; Zlobec I; Pallante P; Sepe R; Esposito F; Zimmermann A; Diamantis I; Terracciano L; Fusco A; Karamitopoulou E
Histopathology; 2012 Feb; 60(3):397-404. PubMed ID: 22276603
[TBL] [Abstract][Full Text] [Related]
17. FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma.
Gao L; Lang L; Zhao X; Shay C; Shull AY; Teng Y
Oncogene; 2019 Mar; 38(13):2394-2404. PubMed ID: 30518874
[TBL] [Abstract][Full Text] [Related]
18. The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.
Sumter TF; Xian L; Huso T; Koo M; Chang YT; Almasri TN; Chia L; Inglis C; Reid D; Resar LM
Curr Mol Med; 2016; 16(4):353-93. PubMed ID: 26980699
[TBL] [Abstract][Full Text] [Related]
19. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
Cao XP; Cao Y; Zhao H; Yin J; Hou P
Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
[TBL] [Abstract][Full Text] [Related]
20. Lessons from the Crypt: HMGA1-Amping up Wnt for Stem Cells and Tumor Progression.
Resar L; Chia L; Xian L
Cancer Res; 2018 Apr; 78(8):1890-1897. PubMed ID: 29618461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
